Hypocrisy in Healthcare—Professional vs. Patient ESRD Modality Choices

An anonymous online UK survey of renal healthcare workers had 858 responses to two hypothetical questions about their own dialysis modality choice. While PD and home HD were strongly preferred, more than 80% of ESRD patients in the UK still receive standard in-center HD.

Read the abstract » | (added 2023-09-13)

Tags: Dialysis Modality, ESRD Modality

Incremental PD and Patient Outcomes: Registry Data

Between 2007 and 2017, incremental PD use increased by 2.7% in the ANZDATA database. Most (67%) used the approach for one year or less. After controlling for patient and center variables, starting PD with incremental treatments reduced peritonitis risk and transfers to in-center HD, with no increase in mortality.

Read the abstract » | (added 2023-09-13)

Tags: Incremental PD, Incremental Treatments, Peritonitis, Mortality Rate

Outcomes with PD to HHD Compared to Direct HHD

Analysis of data from all patients who started PD or HHD in the first 90 days of kidney replacement therapy in Canada matched PD+HHD patients (n=163) 1:1 to incident HHD patients (n=711). Interestingly, while hospitalization risk was similar, clinical outcomes were better in the PD+HHD group.

Read the abstract » | (added 2023-09-13)

Tags: PD, HHD, Kidney Replacement Therapy, Clinical Outcomes

Incremental PD and Quality of Life

In a 4-year study (2015-2019) of adults starting PD and followed for one year, those who used incremental PD had better KDQOL physical composite, burden of kidney disease, and effects of kidney disease scores, as well as less hospitalization and lower mortality rates (non-significant).

Read the abstract » | (added 2023-09-13)

Tags: Incremental PD, KDQOL, Mortality Rate, Quality Of Life

Skilled Nursing Facility “Home” Dialysis Improves Rehabilitation

Rehab therapies take time—and so does going off-site for in-center dialysis. Offering more frequent dialysis (MFD) at SNFs saves time. Does it improve PT participation? Yes, finds a new retrospective EMR review study. Compared to 562 in-center HD rehab patients, 92 people who received MFD in their SNF had higher PT participation rates (equivalent to almost 13,000 non-ESRD rehab patients), even though they had significantly more comorbidities.

Read the abstract » | (added 2023-08-16)

Tags: Rehabilitation Therapies, Skilled Nursing Facility, MFD, SNF, PT Participation, Comorbidities

Meta-analysis of Quality of Life by ESRD Treatment Modality

Analysis of 111 papers with more than 50,000 patients compared transplant, PD, home HD, and in-center HD for health-related quality of life outcomes. The rankings? Transplant, PD, home HD, in-center HD.

Read the abstract » | (added 2023-08-16)

Tags: Quality Of Life, ESRD, Treatment Modality

Disparities in Access to PD

Per logistic regression of USRDS data from 2009 to 2019, the incident PD population more than doubled, with increases in PD use by seniors. There was a 5% increase in PD use by Hispanic people, but no difference in other races. Urban PD use also increased by 5%, and 7% for those in socioeconomically disadvantaged areas.

Read the abstract » | (added 2023-08-16)

Tags: Incident PD, PD Access, Disparity, PD Demographics

Systematic Review of Culture-directed Antibiotics for Peritonitis

A review of 28 articles identified 18 antibiotics used for peritonitis, of which 9 (cefotaxime, ceftriaxone, daptomycin, ofloxacin, and teicoplanin in glucose-based solutions, tobramycin in Extraneal solution only and fosfomycin in Extraneal, Nutrineal, Physioneal 1.36% and 2.27% glucose solutions ) can be dosed interaperitoneally. Stability has not yet been demonstrated for all of these.

Read the abstract » | (added 2023-08-16)

Tags: Peritonitis, Antibiotics, Culture directed Antibiotics, Peritoneal Dialysis Solutions

ISPD Proposes to Remove PD Toxin Clearance Targets

New ISPD Guidelines suggest that the focus of PD should be patient well-being—not lab values. This change would allow more people to do PD, and focusing on relieving uremic symptoms could help determine which solutes really do matter to quality of life.

Read the abstract » | (added 2023-08-16)

Tags: PD, Patient Well being, Lab Values, Uremic Symptoms, Quality Of Life

How Glucose Causes Peritoneal Fibrosis

Constant glucose exposure from PD dialysate often causes fibrosis that can make further PD impossible. High glucose causes chronic inflammation, interferes with lipid metabolism, and leads to angiogenesis and fibrosis. RAAS activation contributes to this process as well. There may be benefit to looking at the upstream pathways to see if there are ways to block fibrosis.

Read the abstract » | (added 2023-08-16)

Tags: High Glucose, PD Dialysate, Fibrosis